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Interaction between proximal tubular epithelial cells
and infiltrating monocytes/T cells in the proteinuric
state
KN Lai1, JCK Leung1, LYY Chan1, H Guo1 and SCW Tang1
1Division of Nephrology, Department of Medicine, Queen Mary Hospital, The University of Hong Kong, Hong Kong, China
We hypothesize an interaction between T cells/monocytes
and the tubules in the development of tubulointerstitial
injury in chronic proteinuric nephropathy. We established
in vitro co-culture systems of proximal tubular epithelial cells
(PTEC) and T cells/monocytes to study the contribution of
soluble factors and cell-to-cell contact in the development of
tubulointerstitial injury. The release of monocyte
chemoattractant protein-1 (MCP1 or CCL2), Regulated upon
Activation, normal T cell Expressed and Secreted (RANTES or
CCL5), soluble intracellular adhesion molecules-1 (sICAM-1),
or interleukin-6 (IL-6) was increased in PTEC following apical
exposure to human serum albumin (HSA). The release of
CCL2, CCL5, or sICAM-1 from PTEC was enhanced by contact
of monocytes/T cells on the basolateral surface. Tumor
necrosis factor-a (TNF-a) and IL-1b are important soluble
factors as suggested by the blocking effect of antibodies
(Abs) against TNF-a or IL-1b but not against other cytokines.
The percentage of CD4þ T cells expressing both chemokine
receptors, CCR2 and CCR5, was increased after culturing with
supernatant from the apical or basolateral surface of PTEC
following apical exposure to HSA. However, only CCR2 was
upregulated in CD8þ T cells, whereas CCR5 expression was
increased in monocytes. The chemotaxis of CD4þ or CD8þ
T cells to supernatant from PTEC upon apical exposure to
HSA was reduced with neutralizing Abs against CCL5 and/or
CCL2, whereas the chemotaxis of monocytes was only
reduced by anti-CCL5 but not by anti-CCL2. In summary,
chemokines released by HSA-activated PTEC are amplified by
monocytes/T cells. Mediators released by HSA-activated PTEC
can differentially modulate the expression of chemokine
receptors in monocytes/T cells and hence, alter their
chemotaxis towards activated PTEC. These interactions are
pivotal in the development of tubulointerstitial injury.
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Tubulointerstitial damage with scarring is the final common
pathologic pathway in many forms of chronic proteinuric
renal diseases. The severity of tubulointerstitial injury
correlating with the amount of proteinuria1 is a major
determinant of the rate of progression of renal failure.2 The
putative role of urinary proteins, taken to reflect the degree of
protein trafficking through the glomerular capillary, in
inducing tubulointerstitial changes is supported by clinical
observations3 as well as animal models of protein overload4
and experimental nephrotic syndrome.5,6 The mechanisms
through which urinary proteins induce tubulointerstitial
damage however remain largely unknown.
Emerging evidence indicates that interstitial injury
induced by proteinuria may be mediated through activation
of tubular epithelial cells.7 One constant feature of chronic
proteinuric nephritis is the concomitant presence of tubulo-
interstitial inflammation characterized by the infiltration of
mononuclear leukocytes, notably T cells, monocytes, and
macrophages.8 The stimuli responsible for the initial
recruitment of inflammatory cells into the interstitium are
not fully understood, but chemokines secreted by tubular
cells almost certainly play a pivotal role. For instance, monocyte
chemoattractant protein-1 (MCP1 or CCL2), interleukin-8
(CXCL8 or IL-8), and Regulated upon Activation, normal T cell
Expressed and Secreted (RANTES or CCL5) are upregulated by
albumin in cultured proximal tubular epithelial cells
(PTEC).9–11 Despite known chemotactic activities of PTEC for
monocytes and T cells in orchestrating tubulointerstitial
infiltrates in proteinuric renal disease, the nature of interactions
between PTEC and T cells/monocytes via cell-to-cell contact or
soluble factors remains unclear.
In this study, we present our in vitro findings using a co-
culture system of PTEC and T cells/monocytes to study their
interactions that lead to tubulointerstitial injury. The
modulation of the chemokine receptor expression in
monocytes/T cells and hence, their subsequent chemotactic
responses towards activated PTEC were explored.
RESULTS
Expression of chemokine in PTEC exposed to albumin
We first studied the polarity of chemokine release in PTEC
exposed to human albumin mimicking the proteinuric state.
At the quiescent state, detectable levels of CCL2, CCL5,
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soluble intracellular adhesion molecules-1 (sICAM-1), and
IL-6 were found in both apical and basolateral chambers of
the Transwell indicating the release of these chemokines from
the apical as well as the basolateral surface of PTEC (Figure
1a). Upon the acute exposure of the apical membrane of
PTEC to human serum albumin (HSA), there was significant
increase in chemokine release from the apical and basolateral
surfaces. Similar increase of chemokine release was not
observed when the basolateral membrane of PTEC was
exposed to identical concentration of HSA (Figure 1b).
Exposure to transferrin resulted in similar finding with a
smaller magnitude (Figure 1c and d).
Increased chemokine release from PTEC in a proteinuric state
following modulation by monocytes/T cells
We next examined the relative contribution from soluble
factors or cell-to-cell contact in the interaction between
T cells/monocytes and PTEC in the development of
tubulointerstitial inflammation. In principle, the system I
predominantly represented interaction between soluble
factors and the basolateral surface of PTEC, whereas system
II allowed cell-to-cell contact between the T cells/monocytes
and PTEC in addition to soluble factors (Figure 2a). For
system II, a physical contact between PTEC and mononuclear
cells was demonstrated (Figure 2c). Assaying the albumin
concentration in the compartments of both systems revealed
that the gradient of HSA was maintained over the time
course in our experiments (Table 1). The upregulation
of CCL2, CCL5, and sICAM-1 release by PTEC following
apical exposure to albumin was further enhanced when PTEC
were co-stimulated by different T-cell populations or
monocytes either mediated by soluble factors or through
cell-to-cell contact (Figures 3 and 4). The increased
chemokine release was detected in both apical and basolateral
surfaces. Notably, the release of CCL2 or CCL5 was
significantly higher from the basolateral surface (Po0.001),
whereas the release of IL-6 was higher from the apical surface
(Po0.01). Using the same culture system with no PTEC on
the membrane of the insert, we found no increased release of
IL-6, sICAM-1, CCL2, or CCL5 by T cells or monocytes alone
upon exposure to albumin (Table 2). Neither co-incubation
of T cells/monocytes with PTEC without exposure to
albumin increased the release of IL-6, sICAM-1, CCL2, or
CCL5 (Table 2).
Phenotypic change in T cells or monocytes after culture in
both systems was observed (Table 3). Expression of CD25 on
T cell subsets and CD16 on monocytes was significantly
upregulated in system II (Po0.05) but not in system I.
Chemotactic activity in monocytes/T cells following
interaction with PTEC in proteinuric state
We then studied the chemotaxis of different T-cell subsets
and monocytes upon exposure to conditioned medium
from PTEC preincubated with HSA on the apical
surface. Three identical sets of monocytes or T cells
(CD3þ , CD4þ , or CD8þ T cells; 5 105 each) were
prepared. The first set was used for determination of
chemokine receptor expression at baseline before chemotac-
tic challenge with conditioned PTEC media. The remaining
two sets of these cells were seeded onto the upper chamber
of the Transwell insert (with 3mm membrane) and were
cultured for 2 h with the presence of HSA-PTEC conditioned
medium (apical or basolateral) in the lower chamber of
the Transwell. There was no change in the chemotactic
activity of T cells or monocytes in terms of CCR1 expression
by conditioned apical or basolateral media (Figure 5).
The chemotactic activity of CD4þ cells expressing CCR2
was enhanced by conditioned apical or basolateral medium.
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Figure 1 | Polarized release of CCL2, CCL5, sICAM-1, and IL-6 by PTEC. (a) Increased chemokine release by PTEC was observed only when
HSA was added to the apical chamber of the Transwell. (b) No change in chemokine release by PTEC was observed when HSA was added to the
basolateral chamber of the Transwell. (c) Increased chemokine production by PTEC was observed only when transferrin was added to the apical
chamber of the Transwell. (d) No change in chemokine release by PTEC was observed when transferrin was added to the basolateral chamber
of the Transwell Results are means7s.d. obtained from five separate experiments. **Po0.01 and *Po0.05 versus values with control medium
from corresponding apical or basolateral compartment.
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Neither CD8þ T cells nor monocytes expressing CCR2
showed significant changes. Similarly, the chemotactic
activity of CD4þ cells expressing CCR5 was enhanced by
conditioned apical or basolateral medium. In contrast,
the chemotactic activity of CD8þ cells or monocytes
expressing CCR5 was enhanced only by conditioned baso-
lateral medium.
Mediators involved in the chemotaxis of monocytes/T cells
following interaction with PTEC in proteinuric state
We examined the mediators involved in chemotactic activity
following interaction with the PTEC in proteinuric state.
CCL2 and CCL5 were examined for the role as mediators
involved in the chemotactic activity of infiltrating T
cells and monocytes (Figure 6). In both CD4þ and
System Ia b c
System I System II
System II
Cells were added to basolateral side of PTEC
No direct cell contact
Cells were added to basolateral side of PTEC
Direct cell contact possibe
0.4 m pore
3 m pore
Figure 2 | Setup for co-culturing PTEC and monocytes/T-cells to study the crosstalk between monocytes/T cells and PTEC preincubated
with HSA. (a) Two culture systems were used to delineate the contribution of soluble factors and cell-to-cell contact in the crosstalk between
monocytes/T cells and PTEC preincubated with HSA. In system I, PTEC and monocytes/T cells (5 104 each) were physically separated in
different chambers with monocytes/T cells seeded into the basolateral chamber) by 0.4-mm pore size semi-permeable membranes (which
effectively inhibited cell movement) while sharing the same medium. In system II, PTEC (5 104 in 300 ml medium) were first seeded onto the
bottom surface of inverted insert (onto a 3-mm pore size semi-permeable membrane) for 4 h to allow cell anchorage. The culture insert was
then flipped over and the same numbers of T cells or monocytes were seeded onto the other surface of the chamber. (b) In system I, T cells or
monocytes (arrow; stained green by fluorescein isothiocyanate-anti-CD45) are much bigger as compared with the 0.4-mm pore. (c) In system II,
T cells or monocytes (arrowhead; stained green by fluorescein isothiocyanate-anti-CD45) can contact with cultured PTEC through the 3-mm
pore (white circle). Transverse section shows the transmigration of the T cells/monocytes through the pore. Cell nuclei were counterstained
with 40,6-diamidino-2-phenylindole diacetate (blue). Original magnification  400.
Table 1 | HSA concentration (mg/ml) in apical and basolateral compartment of the insert in Culture System I and II (all data
were expressed as means7s.d. of five separate experiments)
Time (h) after addition of HSA
0 1.5 3 6 12 24
System I
Apical
Mean 5.04 4.75 4.64 4.58 4.36 4.25
s.d. 0.08 0.11 0.07 0.06 0.12 0.08
Basolateral
Mean 0.00 0.20 0.24 0.29 0.41 0.68
s.d. 0.00 0.01 0.02 0.02 0.03 0.04
System II
Apical
Mean 5.02 4.54 4.41 4.22 4.13 4.19
s.d. 0.06 0.25 0.14 0.13 0.10 0.14
Basolateral
Mean 0.00 0.17 0.20 0.24 0.35 0.38
s.d. 0.00 0.01 0.02 0.02 0.03 0.02
HSA, human serum albumin.
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CD8þ T cells, the chemotactic activity induced by HSA-PTEC
conditioned medium (apical or basolateral) was suppressed by
anti-CCL2 and anti-CCL5. The two antibodies (Abs) exerted an
additive effect. In contrast, the chemotactic activity in
monocytes induced by HSA-PTEC conditioned medium (apical
or basolateral) was suppressed by anti-CCL5 but not by anti-
CCL2. The two Abs failed to exert an additive suppressive effect.
Expression of chemokine receptors in monocytes/T cells
following interaction with PTEC in proteinuric state
We next examined the expression of chemokine receptors on
monocytes or T cells that had been exposed to conditioned
medium from PTEC preincubated with HSA on the
apical surface (Figure 7). After overnight incubation,
monocytes or T cells were harvested and the expression of
chemokine receptors CCR1, CCR2, and CCR5 were deter-
mined by flow cytometry. The CCR1 expression was not
altered by conditioned apical or basolateral medium. The
CCR2 expression in both CD4þ and CD8þ cells was
enhanced following exposure to conditioned media. The
magnitude was greater with basolateral than apical medium
in CD4þ cells, but the difference between basolateral
and apical medium was not significant in CD8þ cells.
In contrast, there was decreased expression of CCR2 in
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Figure 3 | Release of mediators PTEC co-cultured with monocytes/T cells with no cell contact (System I). Release of (a) CCL2, (b) CCL5,
(c) sICAM-1, and (d) IL-6 by PTEC co-cultured with monocytes/T cells with no cell contact (System I). PTEC were exposed to 5 mg/ml HSA on the
apical surface. Results are means7s.d. obtained from five separate experiments. **Po0.01 and *Po0.05 versus values with conditioned
medium (PTEC with HSA only) from corresponding apical or basolateral compartment.
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Figure 4 | Release of mediators by PTEC co-cultured with monocytes/T cells with cell contact (System II). Release of (a) CCL2, (b) CCL5,
(c) sICAM-1, and (d) IL-6 by PTEC co-cultured with monocytes/T cells with cell contact (System II). PTEC were exposed to 5 mg/ml HSA on the
apical surface. Results are means7s.d. obtained from five separate experiments. **Po0.01 and *Po0.05 versus values with conditioned
medium (PTEC with HSA only) from corresponding apical or basolateral compartment.
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Table 2 | Chemokines and IL-6 concentration in T cells and monocytes cultured with HSA or co-cultured with PTEC (all data
were expressed as means7s.d. of five separate experiments)
 + + + + +    
HSA PTEC PTEC T cell CD4+ CD8+ Monocyte PTEC and T cell PTEC and CD4+ PTEC and CD8+ PTEC and monocyte
CCL2
System I Apical
Mean 7.54 22.70 0.90 0.98 0.83 0.98 7.77 7.92 7.69 8.07
s.d. 0.53 2.11 0.83 0.60 0.75 0.53 1.28 1.13 1.43 0.90
Basolateral
Mean 7.91 36.94 1.27 1.11 0.95 1.82 8.62 8.86 8.62 9.49
s.d. 0.40 2.77 1.66 1.42 0.95 1.34 0.87 1.34 0.95 1.66
System II Apical
Mean 7.78 24.38 0.93 1.01 0.86 1.01 8.01 8.17 7.94 8.32
s.d. 0.44 2.26 0.86 0.62 0.78 0.54 1.32 1.17 1.48 0.93
Basolateral
Mean 7.51 35.57 1.20 1.05 0.90 1.73 8.19 8.41 8.19 9.01
s.d. 0.30 3.33 1.58 1.35 0.90 1.28 0.83 1.28 0.90 1.58
CCL5
System I Apical
Mean 5.89 11.60 0.53 0.71 0.88 0.77 6.36 6.13 5.95 6.36
s.d. 0.71 1.88 0.41 0.53 0.59 1.35 0.71 0.65 0.53 1.00
Basolateral
Mean 6.01 18.93 0.72 0.84 0.96 1.20 6.55 6.73 6.43 7.15
s.d. 0.66 3.07 0.90 1.02 1.20 2.10 1.14 0.66 0.90 0.60
System II Apical
Mean 5.92 12.23 0.53 0.71 0.89 0.77 6.39 6.16 5.98 6.39
s.d. 0.58 1.27 0.41 0.53 0.59 1.36 0.71 0.65 0.53 1.01
Basolateral
Mean 5.67 20.83 0.68 0.79 0.91 1.13 6.18 6.35 6.07 6.75
s.d. 0.43 2.51 0.85 0.96 1.13 1.98 1.08 0.62 0.85 0.57
sICAM-1
System I Apical
Mean 4.05 8.26 0.41 0.45 0.32 0.49 4.21 4.29 4.09 4.78
s.d. 0.49 1.46 0.73 0.36 0.61 0.81 0.57 0.36 0.45 0.89
Basolateral
Mean 2.12 3.41 0.25 0.32 0.21 0.32 2.37 2.52 2.23 2.46
s.d. 0.23 0.72 0.28 0.23 0.34 0.38 0.19 0.23 0.42 0.30
System II Apical
Mean 2.31 4.74 0.21 0.23 0.16 0.25 2.43 2.47 2.38 2.47
s.d. 0.13 0.67 0.42 0.21 0.35 0.46 0.32 0.21 0.25 0.51
Basolateral
Mean 3.78 5.93 0.49 0.68 0.53 0.83 4.31 4.38 4.12 4.46
s.d. 0.25 1.30 0.49 0.42 0.60 0.68 0.34 0.42 0.76 0.53
IL-6
System I Apical
Mean 4.67 28.81 0.56 0.70 0.65 0.75 5.23 5.04 5.09 5.14
s.d. 0.39 1.35 0.51 0.37 0.28 0.65 0.65 0.42 0.51 0.70
Basolateral
Mean 4.58 8.20 0.60 0.78 0.69 1.01 4.85 4.90 4.67 5.04
s.d. 0.55 1.42 0.55 0.41 0.32 0.78 0.60 0.50 0.37 0.55
System II Apical
Mean 4.67 29.40 0.70 0.79 0.61 0.98 5.09 5.18 4.95 5.14
s.d. 0.39 2.37 0.51 0.37 0.28 0.65 0.65 0.42 0.51 0.70
Table 2 is continued on next page
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Table 2 | Continued
 + + + + +    
HSA PTEC PTEC T cell CD4+ CD8+ Monocyte PTEC and T cell PTEC and CD4+ PTEC and CD8+ PTEC and monocyte
Basolateral
Mean 4.55 8.59 1.32 1.46 0.96 1.77 5.41 5.32 5.14 5.64
s.d. 0.40 1.82 0.55 0.41 0.32 0.78 0.60 0.50 0.37 0.55
CCL2, monocyte chemoattractant protein-1; CCL5, Regulated upon Activation, normal T cell Expressed and Secreted; HSA, human serum albumin; PTEC, proximal tubular
epithelial cells; sICAM-1, soluble intracellular adhesion molecules-1.
Concentration was expressed as: CCL2 ( ng 0.1 per 0.5 105 cells); CCL5 (pg 10 per 0.5 105 cells); sICAM-1 (ng per 0.5 105 cells); IL-6 (ng per 0.5 105 cells).
Table 3 | Expression of CD25 in T cells and CD16 in monocytes (all data were expressed as means7s.d. of five separate
experiments)
% CD25+ T-cell subset % CD16+ monocyte
Before culture After culture Before culture After culture
System I
CD3+ Mean 6.98 8.15 Mean 37.53 44.85
s.d. 1.02 1.53 s.d. 4.14 5.51
CD4+ Mean 7.93 9.88
s.d. 1.16 1.38
CD8+ Mean 7.40 7.60
s.d. 0.98 0.93
System II
CD3+ Mean 6.98 9.60* Mean 37.53 49.85*
s.d. 1.02 0.98 s.d. 4.14 5.17
CD4+ Mean 7.93 11.03*
s.d. 1.16 1.16
CD8+ Mean 7.40 7.73
s.d. 0.98 0.92
*Po0.05 before culture versus after culture.
100
CD3+ CD4+
CD8+ Monocyte
NS
NS NS
NS
NS
NS
80
Before
chemotaxis
Apical 
HSA-PTEC 
conditioned medium
Basolateral 
HSA-PTEC 
conditioned medium
Before
chemotaxis
Apical 
HSA-PTEC 
conditioned medium
Basolateral 
HSA-PTEC 
conditioned medium
Before
chemotaxis
Apical 
HSA-PTEC 
conditioned medium
Basolateral 
HSA-PTEC 
conditioned medium
Before
chemotaxis
Apical 
HSA-PTEC 
conditioned medium
Basolateral 
HSA-PTEC 
conditioned medium
%
 C
D3
+ 
ce
ll
%
 C
D4
+ 
ce
ll
60
40
20
0
100
80
60
40
20
0
100
80
60
40
20
0
100
80
%
 C
D8
+ 
ce
ll
%
 M
on
oc
yt
e
60
40
20
0
a b
c d
Figure 5 | Effect of HSA-PTEC conditioned medium on chemotactic capacity of monocytes/T cells. Expression of chemokine receptors
CCR1 (plain bar), CCR2 (dotted bar), and CCR5 (striped bar) in different subset of T cells (a) (CD3þ , (b) CD4þ , or (c) CD8þ T cells) as well as (d)
monocytes harvested from the upper chamber following exposure to HSA-PTEC conditioned medium in the lower chamber of the Transwell.
Results are means7s.d. obtained from five separate experiments and are expressed as percentage of T-cell subset/monocyte expressing
specific chemokine receptors. **Po0.01 and *Po0.05 versus baseline values in the corresponding subset. NS signifies statistically not
significant.
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monocytes exposed to conditioned media. The CCR5
expression in CD3þ , CD4þ cells and monocytes was
enhanced following exposure to conditioned medium
from PTEC preincubated with HSA, more with basolateral
than the apical medium. The CCR5 expression in CD8þ
cells was not significantly altered under identical experi-
mental condition.
Mediators involved in the chemokine release by PTEC
following modulation by monocytes/T cells
In order to understand which mediators were involved in the
chemokine release by PTEC following mononuclear cell
infiltration in the pathological setting of interstitial injury, we
conducted inhibition studies with neutralizing Abs based on
the hypothesis that mediators are released from infiltrating
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Figure 6 | Chemotaxis of monocytes/T cells: effects of neutralizing anti-CCL2 or anti-CCL5 antibodies. Monocytes or T cells seeded onto
the upper chamber of the Transwell insert were cultured for 2 h with HSA-PTEC conditioned media (apical: light bar or basolateral medium:
dark bar) added to the lower chamber of the Transwell. The number of (a) CD3+T cells, (b) CD4+ T cells, (c) CD8+ T cells or (d) monocytes
migrated to the lower chamber of the Transwell was counted. Results are means7s.d. obtained from five experiments and are expressed as
percentage of total number of input T-cell subset/monocyte. **Po0.01 and *Po0.05 versus baseline values in the corresponding subset. NS
signifies statistically not significant.
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mononuclear cells to interact with tubular cells that
potentiate the tubulointerstitial inflammation. As shown
previously, exposure of PTEC to HSA at the apical surface led
to increased release of CCL2, CCL5, sICAM-1, and IL-6
(Po0.01). The release of these chemokines was further
enhanced following addition of either CD3þ T cells or
monocytes to the lower chamber facing the basolateral
surface of PTEC (Figure 8).
To explore whether nuclear factor-kB (NF-kB) activation
mediates chemokine release in PTEC, cells were treated with
a NF-kB inhibitor, pyrrolidine dithiocarbamate (PDTC)
(25 mM) for 30 min before and during incubation with HSA.
Treatment with PDTC attenuated chemokine release from
PTEC following apical exposure to albumin and simulta-
neous basolateral stimulation by mediators from T cells or
monocytes. Treatment of neutralizing Ab against leukocyte
function-associated antigen-1 (LFA-1) (CD11a) (10 mg/ml)
attenuated the release of CCL5 and sICAM-1 from both
apical and basolateral surface and IL-6 from the apical surface
of PTEC. However, anti-LFA-1 exhibited no suppressive
effect on the release of CCL2 from PTEC upon apical
exposure to HSA in the presence of T cells or monocytes in
the lower chamber.
We then looked for the mediators involved in the
chemokine release from PTEC. Both IL-1b and tumor
necrosis factor-a (TNF-a) concentrations were elevated in
the supernatant of the upper chamber (235 and 339%,
respectively, above baseline values, 45716 pg/ml for TNF-a
and 1875.8 for IL-1b, Po0.01), whereas there was no
change in transforming growth factor-b (TGF-b) or platelet-
derived growth factor (PDGF) concentration. Only anti-
TNF-a (0.1 mg/ml) and anti-IL-1b (0.1 mg/ml) were effective
in abrogating release of CCL2, CCL5, sICAM-1, and IL-6 in
PTEC following exposure to albumin at the apical surface
and stimulated by mediators from T cells or monocytes at the
basolateral surface simultaneously. Other neutralizing Abs,
including anti-PDGF, anti-TGF-b , and anti-INF-g failed to
exert similar suppressive effect (Figure 8).
DISCUSSION
Over the past decade, there has been intense interest in the
possible link between excessive protein trafficking through
the glomerulus and progressive tubulointerstitial inflamma-
tion leading to chronic renal failure. Infiltration of activated
leukocytes into injured tissue is a hallmark of inflammation.
This step is critically dependent on the rapid release of
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chemokines.12 In the nephrotic state, the glomerular ultra-
filtrate contains plasma proteins. Previous data show that
overexposure to filtered proteins upregulates tubular expres-
sion of vasoactive and proinflammatory mediators, such as
endothelin-1,13 CCL2,9,14 CCL5,10 and more recently from
us, C3,15 macrophage migration inhibitory factor,16 and
CXCL8.11 These proinflammatory chemokines are respon-
sible for recruiting and activating neutrophils, T cells, and
monocytes at sites of inflammation.11,17 A few recent studies
have suggested distinct T cell and PTEC interactions are
regulated by differential chemokine production and chemo-
kine receptor expression in tubulointerstitial injury in
chronic glomerulonephritides.18–20 Fine mapping of the
crosstalk between T cells and PTEC in interstitial injury
cannot be drawn due to the experimental design of these
studies despite these attractive hypothetical interactions. It
also remains speculative to interpret functional interactions
only based on histology of renal biopsy.14,20 For those in vitro
studies using cultured PTEC, tubular cells were stimulated
directly with exogenous recombinant chemokines or, some-
times, with T-cell membrane preparations.18,19 The concen-
tration of chemokines in the glomerular ultrafiltrate was not
accurately defined. Moreover, usually several chemokines are
present in the glomerular ultrafiltrate and they may exert
synergistic or antagonistic action. Most importantly, the
unique feature of the polarity of chemokine release in PTEC
had never been addressed in these studies. Hence, a better in
vitro culture system that mimics the milieu of chronic
glomerulopathic proteinuric state is needed for any critical
analysis of cellular interactions in the pathogenesis of
tubulointerstitial injury.
In this study, we first demonstrated that significant
increase in chemokine release from apical and basolateral
surfaces occurred only when PTEC were exposed to urinary
proteins (e.g. HSA and transferrin) at the apical surface. The
apical exposure to albumin mimics the pathophysiology of
luminal contact of excessive protein trafficking through the
glomerular capillary. Notably, the release of chemokines,
including CCL2 and CCL5 was predominantly from the
basolateral surface revealing the importance of cell polarity in
this pathophysiological process. We also observed a prefe-
rential release of IL-6 at the apical side of PTEC upon
exposure to HSA. Its physiological relevancy is not fully
understood. Unlike CCR2 and CCR5, which play a major role
in interstitial recruitment of leukocyte, IL-6 promotes and
sustains the chronic inflammatory event. Indeed, the apical
production of IL-6 by PTEC exposed to HSA indicates that
IL-6 has the potential for both autocrine and paracrine action
preferentially at the luminal side. We then established co-
culture systems that mimic the milieu where PTEC are
exposed to urinary proteins on the apical surface as in
proteinuric nephropathies, whereas infiltrating mononuclear
cells are recruited from the microcirculation in proximity
with PTEC at the basolateral surface following the release of
chemokines from the basolateral surface. Other than
the release of IL-6 from the basolateral surface, T cells
(CD4þ and CD8þ ) and monocytes amplified the release of
CCL2, CCL5, and sICAM-1 in activated PTEC via humoral
mechanisms. We documented that the chemokine release
following PTEC and T cells/monocytes crosstalk was
dependent on PTEC exposure to albumin. The released
chemokines were not derived from infiltrating cells. TNF-a
and IL-1b are the pivotal humoral factors from the T cells
and monocytes that mediate the proinflammatory effect on
tubulointerstitium as demonstrated by the elevated concen-
tration in the supernatant and the inhibitory studies using
neutralizing Abs. We further confirmed that inhibition of
NF-kB activation interferes with CCL2 and CCL5 release
upon protein overload9,10 and also on the amplifying effect
exerted by infiltrating T cells and monocytes. Our findings
with anti-LFA-1 inhibition support the previous observation
that synthesis of CCL5 in T cells requires the simultaneous
presence of both soluble factors and cell contact.17 In
contrast, cell contact does not appear to be essential for the
release of CCL2 in either T cells or monocytes. At sites of
inflammation, leukocytic interaction with ICAM-1 through
b2-integrin ligation is essential for infiltration of the site and
resolution of injury. Our data from blocking study with anti-
LFA suggest that both sICAM-1 and CCL5 release in our
culture model are dependent on b2-integrin ligation. On the
other hand, the release of CCL2 by PTEC under the present
culture condition is not blocked by pre-incubation leukocytes
with anti-LFA-1 and suggested that CCL2 release is not
driven by the mechanism of cell contact. Some of our
findings are in accord with those of Kuriowa and co-
workers17 yet the experimental conditions are somewhat
different. In their experiment, they used T cells stimulated
with phorbol 12-, myristate 13-acetate and ionomycin
whereas we used quiescent T cells or monocytes in our co-
culture system. In our experimental design, these leukocytes
were stimulated only by chemokines released by PTEC, which
were initially activated following apical exposure to HSA – a
pathologic scenario similar to that of infiltrating leukocytes
recruited from the microcirculation in proximity with PTEC.
Earlier in vitro studies on the responses of activated T cells
to inflammatory chemokines suggest substantial redundancy
in this system.21 However, there is now increasing evidence of
tight specificity of chemokine receptors in defined inflam-
matory states with deployment of different subsets of cells
under firm control. The expression of multiple chemokine
receptors often allows navigation of leukocytes in a
systematic manner through arrays of multiple chemokines
to allow activation, transmigration, tissue migration, and
retention.22 We examined the expression of three chemokine
receptors on monocytes or T cells following the exposure to
conditioned medium from PTEC preincubated with HSA.
CCR1 and CCR5 are constitutively expressed on monocytes
and Th1 cells, whereas CCR2 is expressed on monocytes and
all T cells.23 Our study revealed distinctive patterns of
receptor expression in monocytes and T cells upon exposure
to conditioned medium from PTEC preincubated with HSA.
CD4þ T cells exhibited increased expression of both CCR2
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and CCR5 and the receptor expression was enhanced with
conditioned medium in contact with the basolateral surface
of PTEC. CD8þ T cells only exhibited enhanced CCR2
expression. In contrast, monocytes exhibited enhanced CCR5
expression but reduced CCR2 expression. There was no
change of CCR1 expression in any leukocyte subsets.
Inflammatory cytokines could cause phenotypic change in
monocytes with impaired CCR2 expression and function.24
In our culture systems, CD16þ monocytes were upregulated
and this subset of CD16þ monocytes also had less CCR2
and more CCR5 expression. This could be a protective
mechanism to limit excessive CCL2-driven recruitment of
monocytes to the site of inflammation.
Monocytes and T cells exhibited differential chemotactic
responses following exposure to conditioned medium
from PTEC preincubated with HSA. CD4þ and CD8þ T
cells behaved differently. CD4þ T cells expressing CCR2
or CCR5 exhibited enhanced chemotaxis when exposed
to conditioned medium in contact with the basolateral
surface of PTEC. In contrast, only CD8þ T cells or
monocytes that expressed CCR5 showed increased chemo-
taxis when exposed to conditioned medium in contact
with the basolateral surface of PTEC. There was no change
in chemotaxis in any leukocyte subsets expressing CCR1
despite exposure to different conditioned media from PTEC
preincubated with HSA. Our study revealed different arrays
of chemokines are mediating the chemotactic activity of
leukocytes under the proteinuric state in tubulointerstitial
injury. The chemotactic activity of both CD4þ and CD8þ
T cells is mediated via CCL2 and CCL5 separately with
synergistic action. However, the chemotactic activity of
monocytes is exclusively mediated via CCL5 with no direct
or additive effect from CCL2.
It appears that the tubulointerstitial injury in chronic
proteinuric glomerulonephropathies is under tight and
precise control of chemokine release and receptor expression
orchestrating between tubular cells and infiltrating leuko-
cytes. On the basis of our previous studies11,15 and present
data, we put forth a mechanistic schema summarizing
the cellular and humoral interaction in the pathogenesis
of tubulointerstitial injury under glomerular proteinuric
state (Figure 9). Albumin uptake by PTEC is mediated
through the endocytic receptors, megalin25 and cubilin.26
The albumin-induced upregulation of chemokines
involves nuclear translocation of NF-kB. The ability of the
anti-oxidant, PDTC, to block albumin-induced chemokine
synthesis, coupled with previous observation that reactive
oxygen species activated NF-kB in endothelial cells,27
suggests that oxygen radicals are likely second messengers
in mediating NF-kB activation. NF-kB activation leads
to consequent transcription of chemokines, including
CCL2, CCL5, and CXCL8 with predominant basolateral
release.11 T cells and monocytes recruited from microcircu-
lation infiltrate the kidney in response to chemokines
released by the activated tubular epithelial cells. These
infiltrating mononuclear cells, in turn, enhance further
synthesis of CCL2 and CCL5 by tubular epithelial cells via
soluble factors, such as TNF-a and IL-1b and also via cell-
to-cell-dependent pathways, such as ICAM-1, LFA-1, and
CD40L/CD40.18,28 Chemokines produced by these cells
promote further infiltration of renal interstitium by T cells,
monocytes, and macrophages.29 These events induce a
positive feed-back loop thus amplifying and perpetuating
inflammatory injury in the renal interstitium in chronic
proteinuric state. The release of arrays of multiple chemo-
kines by activated tubular epithelial cells preciously induce
expression of multiple chemokine receptors that allow
navigation of leukocytes to transmigrate, adhere, ligate,
and interact in a systematic manner. Each leukocyte subset
exhibits a unique profile of chemokine receptor expression
and chemotactic activity that directs tight functional
specificity. In essence, the overloading of tubular epithelial
cells with urinary proteins (e.g. albumin) leads to a common
pathway of activating NF-kB-dependent genes whose
chemotactic protein products act in concert to orchestrate
a complex cascade of events that translate the original
glomerulopathy into cellular signals of tubulointerstitial
inflammation. These signals may then be relayed back to
the glomerulus via tubuloglomerular crosstalk mechanisms
to perpetuate further glomerular damage.16 The end result of
these processes is tubular atrophy, interstitial fibrosis, and
loss of renal function.
In summary, chemokines released by HSA-activated
PTEC are amplified by monocytes/T cells through
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mechanisms dependent or independent of cell contact.
Mediators released by HSA-activated PTEC can differentially
modulate the expression of chemokine receptors in mono-
cytes/T cells and hence, alter their chemotaxis towards
activated PTEC.
MATERIALS AND METHODS
Reagents
Medium and reagents for cell culture were obtained from Gibco BRL
(Paisley, UK). Abs for cell characterization and general chemicals
were purchased from Sigma Chemicals (Poole, Paisley, UK). Abs for
flow cytometry analysis (fluorescence-activated cell sorter) of CCR5,
T cell subsets and monocytes were obtained from BD Biosciences
(San Diego, CA, USA). Abs to CCR1 or CCR2, and neutralizing
Abs to CCL2 and CCL5 were obtained from R and D systems
(Minneapolis, MN, USA). All other Abs were from Dako A/S
(Glostrup, Denmark). HSA was obtained from CSL Laboratory
(Parkville, Victoria, Australia). The endotoxin level in all
albumin preparations were o10 EU/ml as determined using the
QCL-1000 Limulus Amebocyte Lysate kit (BioWhittaker Inc.,
Walkersville, MD, USA).
PTEC culture
The study was conducted in accordance with the Declaration of
Helsinki Principle, and was approved by the institutional ethics
committee. Human PTEC were isolated according to a previously
described method.30 Briefly, renal cortical tissue was obtained from
kidneys removed for circumscribed tumors. Histological examina-
tion of these samples revealed no renal pathology. Cortical
specimens were cut into small cubes and passed through a series
of mesh sieves of diminishing pore size. PTEC were collected on the
53-mm sieve, and digested with collagenase (750 U/ml) at 371C for
15 min. Tubular cells were isolated by centrifugation and grown in a
renal epithelial basal medium consisting of a 1:1 mixture of
Dulbecco’s modified Eagle’s medium and Ham’s F12 medium
supplemented with 10% fetal calf serum, hydrocortisone (40 ng/ml),
L-glutamine (2 mM), benzyl penicillin (100 IU/ml), and streptomycin
(100 mg/ml). The cells were incubated at 371C in 5% CO2 and 95%
air. Their proximal tubular origin was characterized by immuno-
fluorescence and enzyme histochemistry: cells stained positively for
cytokeratin, vimentin, and alkaline phosphatase, but negatively
for Tamm–Horsfall glycoprotein, factor VIII-related antigen and
a-smooth muscle actin. Scanning electron microscopy demonstrated
the presence of numerous apical microvilli of a rudimentary
brush border with reassembly of tight junctions. Experiments were
performed with cells up to the third passage with no phenotypic
changes.31 In all experiments, there was a ‘growth arrest’ period
of 24 h in serum-free medium before stimulation. Results were
obtained from PTEC cultured from the kidney of three different
donors.
Examination of polarity of chemokine secretion by PTEC
This was conducted according to techniques previously described.11
Briefly, second passage PTEC were seeded into 12-well Transwell
chambers (0.4 mm pore size, 12 mm diameter; Corning Costar
Corporation, Cambridge, MA, USA) and maintained at confluence
for 2 days before use. Albumin (5 mg/ml) or transferrin (5 mg/ml)
was added either to the upper or lower chamber, which
corresponded to the apical or basolateral side of the cells,
respectively. Medium alone was added to the other compartment.
The albumin and transferrin concentrations were selected based on
our previous studies.11,16 After 24 h incubation, supernatants in the
upper and lower chambers were harvested separately, and assayed
for different chemokines. The cell number was also counted.
Purification of CD3þ , CD4þ , CD8þ T cells and monocytes
Peripheral blood mononuclear cells were isolated from normal
donors by density gradient centrifugation. Monocytes and T cells
(CD3þ , CD4þ , or CD8þ ) were isolated by Dynal Negative
Isolation Kits according to the manufacturer’s protocols (Dynal,
Oslo, Norway). Cell purity was assessed by fluorescence-activated
cell sorter analysis. The T-cell fraction routinely consisted of 480%
CD3-expressing cells, 3% CD14-expressing cells, and 10% CD56-
expressing cells. The purity of selected CD3þ , CD4þ , CD8þ
T cells and monocytes was 496% as determined by fluorescence-
activated cell sorter analysis. The cells viability was greater than 98%
as determined by tryphan blue dye exclusion test.
PTEC and monocytes/T cells co-culture
In order to study the relative contribution of cell-to-cell contact or
soluble factors in the interaction between PTEC and T cells/
monocytes, we established two culture systems to analyze the
mechanisms involved in HSA-induced responses of PTEC (Figure 2).
In system I, PTEC and T cells/monocytes were physically separated
in different chambers by 0.4-mm pore size semi-permeable
membranes for inhibiting cell leakage while sharing the same
medium. T cells/ monocytes were seeded into the basolateral
chamber. In system II, PTEC were first seeded onto the bottom
surface of inverted insert (onto a 3-mm pore size semi-permeable
membrane) for 2 h to allow cell anchorage. The culture insert was
then flipped over and further cultured for 16 h before being arrested.
During the experiment, same number of T cells was seeded onto the
other surface of the chamber. Cell contacts between T cells/
monocytes and the basolateral membrane of the PTEC grown
under the insert were present due to the bigger pore size of the
membrane. To demonstrate the physical contact between PTEC and
mononuclear cells in systems II, experiment was performed using
fluorescein isothiocyanate-anti-CD45 to label mononuclear cells and
40,6-diamidino-2-phenylindole diacetate to post-stain the nucleus of
PTEC. The insert was excised before examination under fluores-
cence microscope. These in vitro set-ups mimic the pathological
milieu where PTEC are exposed to HSA on the apical surface as in
proteinuric nephropathies, whereas infiltrating mononuclear cells
are recruited from the microcirculation in proximity with PTEC at
the basolateral surface.
In preliminary experiments, serial twofold increments (T cells/
monocytes:PTEC; 0.5:1 to 2:1) were examined using IL-6 release to
determine optimal dose response. Although stimulation was
detected at a ratio of 0.5:1, we elected to use the ratio of 1:1
because at this ratio an adequate amount of chemokine was induced
to allow meaningful comparisons without using excessive number of
T cells/monocytes. To determine the stability of albumin gradient in
the culture systems, we assayed the albumin concentration in the
apical and basolateral compartments at different time points
throughout the experimental period by an enzyme-linked immuno-
sorbent assay kit (Bethyl Laboratories Inc., Montgomery,
TX, USA).
The phenotypic change of T cells or monocytes after culture in
both systems was examined by the expression of CD25 on T-cell
subsets and CD16 on monocytes by flow cytometry.
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Determination of chemokine production
Enzyme immunoassay kits for the detection of CCL5 and CCL2
were purchased from Chemicon International (Temecula, CA, USA).
The IL-6, TNF-a, TGF-b, and PDGF, and interferon-g (IFN-g)
concentrations were determined by commercial enzyme-linked
immunosorbent assay from R and D Systems (Minneapolis, MN,
USA). Assay for sICAM-1 was purchased from Bender MedSys-
tems (Vienna, Austria). The detection sensitivities and intra-
assay coefficient of variance were 49 pg/ml77.4% for CCL5,
13.1 pg/ml77.9% for CCL2, 11 pg/ml73.8% for CXCL8, 0.63 ng/
ml76.8% for sICAM-1, 1.5 pg/ml78.6% for IL-1, 3 pg/ml79.5%
for TNF-a, 5 pg/ml77.2% for TGF-b, 2.5 pg/ml78.7% for PDGF,
and 8 pg/ml79.8% for IFNg.
Polarized production of chemokines by PTEC co-cultured
with monocytes/T cells: effect of different neutralizing Abs or
PDTC
Culture system II was used to examine the effect of monocytes or T
cells on chemokines release by PTEC exposed to 5 mg/ml HSA
(apical exposure). In some experiments, PTEC were pre-incubated
30 min with anti-TNF-a (0.1 mg/ml), anti-IL-1b (0.1 mg/ml), anti-
PDGF (100 mg/ml), anti-TGF-b (10mg/ml), anti-IFNg (10mg/ml) or
PDTC (25 mM) before addition of HSA and monocytes/T cells. For
anti-LFA-1 monoclonal Ab, the monocytes/T cells were first
pretreated with anti-LFA-1 (10 mg/ml) for 30 min before adding to
the chamber. After overnight incubation, apical and basolateral
media were harvested for assay of chemokines.
Chemotaxis assay and expression of chemokine receptors
Chemotaxis assay was performed as described previously.32 Mono-
cytes or T cells (CD3þ , CD4þ , or CD8þ T cells; 5 105 each)
were seeded onto the upper chamber of the Transwell insert (with
5 mm membrane) and cultured 2 h with the presence of HSA-PTEC
conditioned media (apical or basolateral medium) in the lower
chamber of the Transwell. Expression of chemokine receptors CCR1,
CCR2, and CCR5 in monocytes or T cells were determined by flow
cytometry before experiments and in cells harvested from the lower
chamber after chemotaxis experiment. For the neutralizing experi-
ments, anti-CCL5 (10mg/ml) or/and anti-CCL2 (10mg/ml) were added
to the lower chamber 30 min before starting the chemotaxis assay. The
number of monocytes or T cells (CD3þ , CD4þ , or CD8þ T cells)
migrated to the lower chamber of the Transwell was counted.
Statistical analysis
All data were expressed as means7s.d. unless otherwise specified.
Inter-group differences for two variables were assessed by Mann
–Whitney test. Inter-group differences for more than two variables
were assessed by multivariate analysis of repeated measurement
followed by Bonferroni’s correction. A two-tailed ‘P’-value of less
than 0.05 was considered statistically significant.
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